Nisa Investment Advisors
HURA

Nisa Investment Advisors’s TuHURA Biosciences HURA Stock Holding History

Nisa Investment Advisors’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-205
Closed -$508 – 3113
2025
Q3 		$508 Buy
+205
New +$540 ﹤0.01% 2857

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $798M AUM 14.62% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nisa Investment Advisors's HURA Position: Q4 2025 in Review

Nisa Investment Advisors sold out of TuHURA Biosciences (HURA) in Q4 2025, closing a stake of 205 shares — an estimated $508 sold.

Nisa Investment Advisors first reported a position in HURA in Q3 2025 and held it in 1 quarter. The position peaked at $508 in Q3 2025. 65 funds tracked by Wall St. Rank hold HURA as of Q4 2025.

  • Nisa Investment Advisors reported no remaining TuHURA Biosciences position as of Q4 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 205 TuHURA Biosciences shares in Q4 2025, an estimated $508.
  • Nisa Investment Advisors first reported a position in TuHURA Biosciences in Q3 2025 and held it in 1 quarter.
  • Nisa Investment Advisors's TuHURA Biosciences position peaked at $508 in Q3 2025.
  • 65 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q4 2025.

Based on Nisa Investment Advisors's 13F filing for Q4 2025, filed 15 Jan 2026.